Immunofluorescence staining revealed the translocation of both GrB and perforin into tumor cells following combination treatment (Fig. 1H), indicating the activation of a perforin/GrB-dependent apoptotic pathway driven by immune cells. Here, GZMB is linked to neoplasm.